Long non-coding RNAs in drug resistance across the top five cancers: Update on their roles and mechanisms
Cancer drug resistance stands as a formidable obstacle in the relentless fight against the top five prevalent cancers: breast, lung, colorectal, prostate, and gastric cancers. These malignancies collectively account for a significant portion of cancer-related deaths worldwide. In recent years, long...
Main Authors: | Yue Shi, Joseph Adu-Amankwaah, Qizhong Zhao, Xin Li, Qianxue Yu, Aisha Bushi, Jinxiang Yuan, Rubin Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024032389 |
Similar Items
-
Reactive Oxygen Species and Long Non-Coding RNAs, an Unexpected Crossroad in Cancer Cells
by: Teodor Paul Kacso, et al.
Published: (2022-09-01) -
Non-Coding RNAs and the Development of Chemoresistance to Docetaxel in Prostate Cancer: Regulatory Interactions and Approaches Based on Machine Learning Methods
by: Elena Pudova, et al.
Published: (2023-12-01) -
The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer
by: Isaac Micallef, et al.
Published: (2021-03-01) -
An Overview of Long Non-Coding (lnc)RNAs in Neuroblastoma
by: Francesca Baldini, et al.
Published: (2021-04-01) -
LncRNAs and CircRNAs in cancer
by: Xin Yin, et al.
Published: (2022-06-01)